Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

Meta-Analysis

Systematic Review

Clinical Trial, Phase III

Comparative Study

Clinical Trial, Phase IV

Scoping Review

Clinical Trial

Research Support, N.I.H., Extramural

Publication Year

From

Quick links

Individual year

2025

2024

2021

2019

2018

2017

2015

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Wakefulness-Promoting Agents""[mesh_terms]

21 Results

Searching titles within these results

A scoping review of the evidence on pharmacological and nonpharmacological interventions for idiopathic hypersomnia.

Shivani Saini, Vishal Saini

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine 2024;20(10):1685-1704

Full Text

Abstract

Idiopathic Hypersomnia and Other Hypersomnia Syndromes.

Lynn Marie Trotti, Isabelle Arnulf

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2021;18(1):20-31

Free Full Text

Abstract

Pharmacological and non-pharmacological management of sleep disturbances in Parkinson's disease: if when and how.

Karolina Popławska-Domaszewicz, Kallol Ray Chaudhuri, Cristian Falup-Pecurariu, Iulia Murasan, Maria-Lucia Muntean, Larisa Ungureanu, Stefania Diaconu

Expert opinion on pharmacotherapy 2024;25(16):2135-2149

Full Text

Abstract

Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis.

Joaquim J Ferreira, Ana Castro Caldas, Tiago Martins Rodrigues

Parkinsonism & related disorders 2017;27():25-34

Full Text

Abstract

Efficacy of once-nightly sodium oxybate (FT218) on daytime symptoms in individuals with narcolepsy with or without concomitant alerting agent use: A post hoc analysis from the phase 3 REST-ON trial.

Richard Bogan, Jennifer Gudeman, Asim Roy, Thomas Roth, Anne Marie Morse, Yves Dauvilliers, Michael J Thorpy

Sleep medicine 2024;124():209-216

Free Full Text

Abstract

Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in patients with narcolepsy participating in two clinical trials of sodium oxybate.

Milton Erman, Helene Emsellem, Jed Black, Fannie Mori, Geert Mayer

Sleep medicine 2018;38():92-95

Free Full Text

Abstract

Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.

Jed Black, Todd Swick, Richard Bogan, Chinglin Lai, Lawrence P Carter

Sleep medicine 2017;24():57-62

Free Full Text

Abstract

Precision Medicine for Idiopathic Hypersomnia.

Pauline Dodet, Smaranda Leu-Semenescu, Isabelle Arnulf

Sleep medicine clinics 2019;14(3):333-350

Full Text

Abstract

Comparative efficacy of new wake-promoting agents for narcolepsy-a network meta-analysis.

Zian Yan, Jiwei Li, Yixin Yu, Shenghan Qiu, Bing Wang, Jiyou Tang

BMC neurology 2025;25(1):466

Free Full Text

Abstract

Caffeine and modafinil modulate the effects of sleep deprivation on thalamic resting-state functional connectivity: A double-blind pilot study.

Letong Wang, Yongcong Shao, Jie Lian, Lin Xu, Jie Chen, Xiao Zhong, Xinxin Gong, Jingjing Gong

Sleep medicine 2024;122():71-83

Full Text

Abstract

An evaluation of sodium oxybate as a treatment option for narcolepsy.

Vivien C Abad

Expert opinion on pharmacotherapy 2019;20(10):1189-1199

Full Text

Abstract

Pharmacological management of narcolepsy with and without cataplexy.

Claudio L Bassetti, Ulf Kallweit

Expert opinion on pharmacotherapy 2017;18(8):809-817

Full Text

Abstract

Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management.

Russell Rosenberg, Paula K Schweitzer, Joerg Steier, Jean-Louis Pepin

Postgraduate medicine 2021;133(7):772-783

Free Full Text

Abstract

Update on treatment for idiopathic hypersomnia.

Yves Dauvilliers, Régis Lopez, Elisa Evangelista

Expert opinion on investigational drugs 2018;27(2):187-192

Full Text

Abstract

Mechanism of action of narcolepsy medications.

Leslie P Lundt, Chandan R Gowda

CNS spectrums 2015;19 Suppl 1():25-33; quiz 25-7, 34

Full Text

Abstract

Results: 1 – 15 / 21

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Wakefulness-Promoting Agents""[mesh_terms]

A scoping review of the evidence on pharmacological and nonpharmacological interventions for idiopathic hypersomnia.

Idiopathic Hypersomnia and Other Hypersomnia Syndromes.

Pharmacological and non-pharmacological management of sleep disturbances in Parkinson's disease: if when and how.

Pharmacological interventions for daytime sleepiness and sleep disorders in Parkinson's disease: Systematic review and meta-analysis.

Efficacy of once-nightly sodium oxybate (FT218) on daytime symptoms in individuals with narcolepsy with or without concomitant alerting agent use: A post hoc analysis from the phase 3 REST-ON trial.

Correlation between the Epworth Sleepiness Scale and the Maintenance of Wakefulness Test in patients with narcolepsy participating in two clinical trials of sodium oxybate.

Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.

Precision Medicine for Idiopathic Hypersomnia.

Comparative efficacy of new wake-promoting agents for narcolepsy-a network meta-analysis.

Caffeine and modafinil modulate the effects of sleep deprivation on thalamic resting-state functional connectivity: A double-blind pilot study.

An evaluation of sodium oxybate as a treatment option for narcolepsy.

Pharmacological management of narcolepsy with and without cataplexy.

Residual excessive daytime sleepiness in patients treated for obstructive sleep apnea: guidance for assessment, diagnosis, and management.

Update on treatment for idiopathic hypersomnia.

Mechanism of action of narcolepsy medications.

Results for
""Wakefulness-Promoting Agents""[mesh_terms]